Biotechnology and the pharmaceutical industry. New cardiovascular drugs.

Biotechnology and the pharmaceutical industry. New cardiovascular drugs.

Technological, Structural, and Strategic Change in the Global Pharmaceutical Industry - The Finnish Biotechnology Industry

This paper reviews the technological, structural, and strategic change within the global pharmaceutical industry, which started in 1973 with the success of recombinant DNA. These changes significantly impact the industry paradigm and the strategy logic of a firm. We then focus on the developments within the Finnish biotechnology industry during the past five years and the future prospects and s...

New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry

Abstract Background and scope: The current situation in Iran suggests a good basis for advancement in biotechnology industries because the patents for many hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies without patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present researc...